Lima Walt F, Wu Hongjiang, Nichols Josh G, Sun Hong, Murray Heather M, Crooke Stanley T
Department of Molecular and Structural Biology, Isis Pharmaceuticals, Inc., Carlsbad, California 92008, USA.
J Biol Chem. 2009 Sep 18;284(38):26017-28. doi: 10.1074/jbc.M109.010835. Epub 2009 Jul 22.
The endonuclease Argonaute2 (Ago2) mediates the degradation of the target mRNA within the RNA-induced silencing complex. We determined the binding and cleavage properties of recombinant human Ago2. Human Ago2 was unable to cleave preformed RNA duplexes and exhibited weaker binding affinity for RNA duplexes compared with the single strand RNA. The enzyme exhibited greater RNase H activity in the presence of Mn2+ compared with Mg2+. Human Ago2 exhibited weaker binding affinities and reduced cleavage activities for antisense RNAs with either a 5'-terminal hydroxyl or abasic nucleotide. Binding kinetics suggest that the 5'-terminal heterocycle base nucleates the interaction between the enzyme and the antisense RNA, and the 5'-phosphate stabilizes the interaction. Mn2+ ameliorated the effects of the 5'-terminal hydroxyl or abasic nucleotide on Ago2 cleavage activity and binding affinity. Nucleotide substitutions at the 3' terminus of the antisense RNA had no effect on human Ago2 cleavage activity, whereas 2'-methoxyethyl substitutions at position 2 reduced binding and cleavage activity and 12-14 reduced the cleavage activity. RNase protection assays indicated that human Ago2 interacts with the first 14 nucleotides at the 5'-pole of the antisense RNA. Human Ago2 preloaded with the antisense RNA exhibited greater binding affinities for longer sense RNAs suggesting that the enzyme interacts with regions in the sense RNA outside the site for antisense hybridization. Finally, transiently expressed human Ago2 immunoprecipitated from HeLa cells contained the double strand RNA-binding protein human immunodeficiency virus, type 1, trans-activating response RNA-binding protein, and deletion mutants of Ago2 showed that trans-activating response RNA-binding protein interacts with the PIWI domain of the enzyme.
核酸内切酶Argonaute2(Ago2)在RNA诱导沉默复合体中介导靶mRNA的降解。我们测定了重组人Ago2的结合和切割特性。人Ago2无法切割预先形成的RNA双链体,与单链RNA相比,其对RNA双链体的结合亲和力较弱。与Mg2+相比,该酶在Mn2+存在时表现出更高的核糖核酸酶H活性。人Ago2对具有5'-末端羟基或无碱基核苷酸的反义RNA表现出较弱的结合亲和力和降低的切割活性。结合动力学表明,5'-末端杂环碱基引发了酶与反义RNA之间的相互作用,而5'-磷酸稳定了这种相互作用。Mn2+改善了5'-末端羟基或无碱基核苷酸对Ago2切割活性和结合亲和力的影响。反义RNA 3'末端的核苷酸取代对人Ago2切割活性没有影响,而第2位的2'-甲氧基乙基取代降低了结合和切割活性,第12 - 14位降低了切割活性。核糖核酸酶保护试验表明,人Ago2与反义RNA 5'-端的前14个核苷酸相互作用。预先加载反义RNA的人Ago2对更长的正义RNA表现出更高的结合亲和力,这表明该酶与反义杂交位点之外的正义RNA区域相互作用。最后,从HeLa细胞中瞬时表达并免疫沉淀的人Ago2包含双链RNA结合蛋白人免疫缺陷病毒1型反式激活应答RNA结合蛋白,Ago2的缺失突变体表明反式激活应答RNA结合蛋白与该酶的PIWI结构域相互作用。